Bronchiolitis obliterans postallogeneic stem cell transplantation: What is new?

被引:2
|
作者
Lemonnier, F. [1 ,2 ]
Dhedin, N. [2 ]
Catherinot, E. [1 ]
Tcherakian, C. [1 ]
Neveu, H. [1 ]
Suarez, F. [3 ]
Becquemin, M. -H. [4 ]
Devillier, P. [5 ,6 ]
Vernant, J. -P. [2 ]
Couderc, L. -J. [1 ,5 ,6 ]
Rivaud, E. [1 ]
机构
[1] Hop Foch, Serv Pneumol, F-92150 Suresnes, France
[2] Grp Hosp Pitie Salpetriere, Serv Hematol Clin, F-75651 Paris 13, France
[3] Hop Necker Enfants Malad, Serv Hematol Clin, F-75743 Paris, France
[4] Grp Hosp Pitie Salpetriere, Serv Explorat Fonct, F-75651 Paris 13, France
[5] Univ Versailles St Quentin En Yvelines, Fac Med Paris Ile de France Ouest, F-78280 Guyancourt, France
[6] Fac Paris Ile de France Ouest, UPRES EA 220, F-92150 Suresnes, France
关键词
Obstructive bronchiolitis; Allogeneic hematopoietic stem cell transplantation; Azythromycin; Imatinib; Lung transplantation; VERSUS-HOST-DISEASE; NONINFECTIOUS PULMONARY COMPLICATIONS; ALLOGENEIC MARROW TRANSPLANTATION; GASTROESOPHAGEAL-REFLUX DISEASE; OBSTRUCTIVE AIRWAYS DISEASE; NECROSIS-FACTOR-ALPHA; AIR-FLOW OBSTRUCTION; BONE-MARROW; LUNG TRANSPLANTATION; PSEUDOMONAS-AERUGINOSA;
D O I
10.1016/j.pneumo.2011.06.003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Bronchiolitis obliterans (BO) is a severe complication of hematopoietic stem cell transplantation (HSCT). It is considered as a respiratory manifestation of chronic graft-versus-host disease. It is quite similar to the bronchiolitis obliterans after lung transplantation. Classical therapy associates steroids and immunosuppressive drugs, however theses procedure showed a modest efficacy and have an important morbidity. Recent progresses in the physiopathology of BO post-HSCT allow to use new treatments: mTOR inhibitors, immunotherapy, extra-corporeal photochemotherapy, and bronchial anti-inflammatory effects of azithromycin, statins or anti-leucotriens. This review will focus on the use of these new therapies in BO post-HSCT. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:258 / 266
页数:9
相关论文
共 50 条
  • [1] Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
    Williams, Kirsten M.
    Chien, Jason W.
    Gladwin, Mark T.
    Pavletic, Steven Z.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (03): : 306 - 314
  • [2] A casecontrol study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
    Nakasone, Hideki
    Kanda, Junya
    Yano, Shingo
    Atsuta, Yoshiko
    Ago, Hiroatsu
    Fukuda, Takahiro
    Kakihana, Kazuhiko
    Adachi, Tatsuya
    Yujiri, Toshiaki
    Taniguchi, Shuichi
    Taguchi, Jun
    Morishima, Yasuo
    Nagamura, Tokiko
    Sakamaki, Hisashi
    Mori, Takehiko
    Murata, Makoto
    TRANSPLANT INTERNATIONAL, 2013, 26 (06) : 631 - 639
  • [3] Bronchiolitis obliterans following hematopoietic stem cell transplantation: a clinical update
    Pandya, Chirag M.
    Soubani, Ayman O.
    CLINICAL TRANSPLANTATION, 2010, 24 (03) : 291 - 306
  • [4] Lung Transplantation for Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation
    Kim, Yu Ri
    Haam, Seok Jin
    Park, Yoon Ghil
    Lim, Beom Jin
    Park, Yoo Mi
    Paik, Hyo Chae
    YONSEI MEDICAL JOURNAL, 2012, 53 (05) : 1054 - 1057
  • [5] How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
    Williams, Kirsten M.
    BLOOD, 2017, 129 (04) : 448 - 455
  • [6] Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation
    Hostettler, Katrin E.
    Halter, Joerg P.
    Gerull, Sabine
    Lardinois, Didier
    Savic, Spasenija
    Roth, Michael
    Tamm, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (01) : 221 - 232
  • [7] Bronchiolitis Obliterans Following Lung Transplantation and Stem Cell Transplantation in Pediatric Patients
    Strawbridge, Heather D.
    Spahr, Jonathan E.
    Galambos, Csaba
    Kurland, Geoffrey
    CURRENT PEDIATRIC REVIEWS, 2010, 6 (03) : 192 - 203
  • [8] Donor Lymphocyte Infusion May Reduce the Incidence of Bronchiolitis Obliterans after Allogeneic Stem Cell Transplantation
    Forslow, Ulrica
    Mattsson, Jonas
    Gustafsson, Thomas
    Remberger, Mats
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (08) : 1214 - 1221
  • [9] Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
    Nakaseko, Chiaki
    Ozawa, Shinichi
    Sakaida, Emiko
    Sakai, Miwa
    Kanda, Yoshinobu
    Oshima, Kumi
    Kurokawa, Mineo
    Takahashi, Satoshi
    Ooi, Jun
    Shimizu, Takayuki
    Yokota, Akira
    Yoshiba, Fumiaki
    Fujimaki, Katsumichi
    Kanamori, Heiwa
    Sakai, Rika
    Saitoh, Takayuki
    Sakura, Tohru
    Maruta, Atsuo
    Sakamaki, Hisashi
    Okamoto, Shinichiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (03) : 375 - 382
  • [10] Budesonide/Formoterol for Bronchiolitis Obliterans after Hematopoietic Stem Cell Transplantation
    Bergeron, Anne
    Chevret, Sylvie
    Chagnon, Karine
    Godet, Cendrine
    Bergot, Emmanuel
    de Latour, Regis Peffault
    Dominique, Stephane
    de Revel, Thierry
    Juvin, Karine
    Maillard, Natacha
    Reman, Oumedaly
    Contentin, Nathalie
    Robin, Marie
    Buzyn, Agnes
    Socie, Gerard
    Tazi, Abdellatif
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (11) : 1242 - 1249